Wordt geladen...
Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells
The canonical WNT-β-catenin pathway is essential for self-renewal, growth and survival of AML stem/blast progenitor cells (BPCs). Deregulated WNT signaling inhibits degradation of β-catenin, causing increased nuclear translocation and co-factor activity of β-catenin with the transcriptional regulato...
Bewaard in:
| Gepubliceerd in: | Leukemia |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4456205/ https://ncbi.nlm.nih.gov/pubmed/25482131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2014.340 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|